洛铂或顺铂联合依托泊苷治疗初治小细胞肺癌临床疗效的观察

首页 > 过刊浏览>2013年第2期 >

洛铂或顺铂联合依托泊苷治疗初治小细胞肺癌临床疗效的观察
DOI:
                        
                    
作者:
                        
                        
                    
作者单位:
作者简介:
通讯作者:
中图分类号:
基金项目:

A Clinical Study on the Short-term Efficacy of Lobaplatin or Cisplatin Combined with Etoposide in Initial Treatment of Small Cell Lung Cancer

Author:

Affiliation:

Fund Project:

摘要

图/表

访问统计

参考文献

相似文献

引证文献

资源附件

文章评论

摘要:

目的评价洛铂联合依托泊苷化疗方案（EL 方案）治疗初治小细胞肺癌（SCLC）的近期疗效和不良反应，并与顺铂联合依托泊苷化疗方案（EP 方案）对比。

Abstract:

Objective To observe the short-term effectiveness and adverse reaction of the chemotherapeutic regimen EL in which lobaplatin combined with etoposide in the initial treatment of small cell lung cancer, and make the comparison with EP regimen in which cisplatin with etoposide.